The U.S. FDA has expanded the Emergency Use Authorization (EUA) for Pfizer Inc. and BioNTech SE’s COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.   “Today’s expansion of our EUA represents a significant step forward in helping the U.S. government broaden its vaccination program and help protect adolescents before the start of the next school year,” said Albert Bourla, chairman and chief executiv...